Moneta Group Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,934
Closed -$489K 822
2025
Q3
$489K Sell
8,934
-1,957
-18% -$97.8K ﹤0.01% 500
2025
Q2
$579K Sell
10,891
-963
-8% -$48.9K 0.01% 407
2025
Q1
$513K Sell
11,854
-33
-0.3% -$1.67K 0.01% 414
2024
Q4
$668K Sell
11,887
-333
-3% -$20.7K 0.01% 340
2024
Q3
$832K Buy
12,220
+580
+5% +$32.7K 0.01% 305
2024
Q2
$492K Buy
11,640
+1,263
+12% +$69.5K 0.01% 392
2024
Q1
$717K Buy
+10,377
New +$656K 0.01% 315
2018
Q1
Sell
-7,334
Closed -$385K 646
2017
Q4
$385K Buy
7,334
+592
+9% +$31.6K 0.06% 144
2017
Q3
$318K Buy
+6,742
New +$271K 0.05% 155

Other funds holding EXAS

Moneta Group Investment Advisors's EXAS Position: Q4 2025 in Review

Moneta Group Investment Advisors sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 8,934 shares — an estimated $489K sold.

Moneta Group Investment Advisors first reported a position in EXAS in Q3 2017 and held it in 9 quarters. The position peaked at $832K in Q3 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Moneta Group Investment Advisors reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 8,934 Exact Sciences shares in Q4 2025, an estimated $489K.
  • Moneta Group Investment Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 9 quarters.
  • Moneta Group Investment Advisors's Exact Sciences position peaked at $832K in Q3 2024.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Moneta Group Investment Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.